Michio Kimura

Ogaki, 5038502, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Relative Dose Intensity and Clinical Outcomes of Using Trifluridine/Tipiracil with or without Bevacizumab in Patients Aged ≥ 75 Years with Advanced or Recurrent Colorectal Cancer: a Single-Center Retrospective Study.

Relative Dose Intensity and Clinical Outcomes of Using Trifluridine/Tipiracil with or without Bevacizumab in Patients Aged ≥ 75 Years with Advanced or Recurrent Colorectal Cancer: a Single-Center Retrospective Study.

Journal: Journal of gastrointestinal cancer

Published: April 02, 2026

Chemoenzymatic method for site-selective fluorophore conjugation of a native IgG Fab fragment.

Chemoenzymatic method for site-selective fluorophore conjugation of a native IgG Fab fragment.

Journal: Journal of bioscience and bioengineering

Published: February 19, 2026

Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer.

Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer.

Journal: Oncology letters

Published: September 14, 2025

Risk Benefit of Single Vial Multiple Use(DVO)Using Anti-Cancer Drug Preparation Robot-DVO Drug Selection Aimed at Both Improving Operational Efficiency and Reducing Medical Costs

Risk Benefit of Single Vial Multiple Use(DVO)Using Anti-Cancer Drug Preparation Robot-DVO Drug Selection Aimed at Both Improving Operational Efficiency and Reducing Medical Costs

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: August 21, 2025

Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving Ramucirumab.

Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving Ramucirumab.

Journal: Anticancer research

Published: August 21, 2025

Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System.

Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting System.

Journal: Oncology

Published: July 24, 2025

Analysis of acute pancreatitis caused by multi-acting receptor-targeted antipsychotics using the Japanese claims database.

Analysis of acute pancreatitis caused by multi-acting receptor-targeted antipsychotics using the Japanese claims database.

Journal: Journal of affective disorders

Published: July 10, 2025

Impact of Promotional Activities on Orexin Receptor Antagonists Prescription Rates and Usage of Sleep and Antipsychotic Medications: An Interrupted Time-series Analysis Study

Impact of Promotional Activities on Orexin Receptor Antagonists Prescription Rates and Usage of Sleep and Antipsychotic Medications: An Interrupted Time-series Analysis Study

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: July 02, 2025

Impact of TAS-102 dose reduction on severe neutropenia and survival outcomes in patients with metastatic colorectal cancer and prior chemotherapy-induced neutropenia.

Impact of TAS-102 dose reduction on severe neutropenia and survival outcomes in patients with metastatic colorectal cancer and prior chemotherapy-induced neutropenia.

Journal: Molecular and clinical oncology

Published: June 27, 2025

Comparison of dose rounding and drug vial optimization for reducing anticancer drug waste.

Comparison of dose rounding and drug vial optimization for reducing anticancer drug waste.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 21, 2025

Safety and Treatment Continuity of Switching between CDK4/6 Inhibitors for Metastatic Breast Cancer due to Adverse Events: An Exploratory Single-Center Study in Japan.

Safety and Treatment Continuity of Switching between CDK4/6 Inhibitors for Metastatic Breast Cancer due to Adverse Events: An Exploratory Single-Center Study in Japan.

Journal: Oncology

Published: April 18, 2025

Spontaneous reporting data cannot show that the risk of pancreatitis with quetiapine is about 30 times greater than with other drugs.

Spontaneous reporting data cannot show that the risk of pancreatitis with quetiapine is about 30 times greater than with other drugs.

Journal: Journal of affective disorders

Published: April 15, 2025

Showing 1-12 of 98

Last Updated: 09/26/2026